CD4 and breast carcinoma: The observed increase in macrophage phagocytosis and tumor-infiltrating CD4+ and CD8+ cells in breast cancer cells suggests that altering macrophage clock gene expression via MCS could enhance the antitumor activity of immune cells against breast cancer.